Close Menu

NEW YORK – Guardant Health's reported after the close of the market on Monday that its fourth quarter 2019 revenues rose 91 percent year over year, driven by continued growth in its precision oncology business.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.